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OBJECTIVES The purpose of this study was to define the role of cell–cell coupling as an independent
determinant of infarct size following coronary occlusion.
BACKGROUND Electrical uncoupling induced by acute ischemia enhances arrhythmogenesis, but it may also
protect the heart by limiting intercellular spread of chemical mediators of injury.
METHODS The left anterior descending coronary artery was ligated in wild-type (Cx43/) mice and
Cx43-deficient (Cx43/) mice that are heterozygous for a null allele in the gene encoding
the major gap junction channel protein, connexin43 (Cx43). Ventricular remodeling and
infarct size were compared in both groups.
RESULTS Echocardiography at 1 and 10 weeks after infarction showed that left ventricular end-diastolic
volume and mass increased and ejection fraction decreased in proportion to infarct size in
both Cx43/ and Cx43/ hearts. However, infarct size measured histologically in healing
infarcts (eight days after infarction) was 29% smaller in Cx43/ hearts (17  14% of total
left ventricular area, n  30) than in Cx43/ hearts (24  15%, n  23; p  0.037). Fully
healed infarcts were smaller than healing infarcts, owing to resorption of necrotic tissue and
maturation of scar, but infarct size at 10 weeks after coronary occlusion was still smaller (by
50%) in Cx43/ hearts (6  5%, n  9) compared with Cx43/ hearts (12  7%, n  17;
p  0.037).
CONCLUSIONS Cx43-deficient mice develop smaller infarcts than wild-type mice following coronary ligation.
New therapies designed to decrease the risk of arrhythmias by enhancing intercellular
communication could lead to larger infarcts caused by persistent coronary occlusion. (J Am
Coll Cardiol 2003;41:681–6) © 2003 by the American College of Cardiology Foundation
Genetic engineering in mice provides an opportunity to
define the role of individual gene products in complex
disease processes. Previously, we analyzed mice that were
heterozygous for a null mutation in the gene encoding the
major ventricular gap junction channel protein, connexin43
(Cx43), to elucidate the role of Cx43 in arrhythmogenesis
induced by acute ischemia. These mice (Cx43/ mice)
express 50% of the wild-type level of Cx43 and, under
physiologic conditions, show no apparent abnormalities of
cardiac structure or function other than modest slowing of
ventricular conduction velocity (1–4). In response to acute
coronary occlusion, however, Cx43/ mice exhibit a sig-
nificantly greater incidence and earlier onset of spontaneous
ventricular arrhythmias (5), indicating that diminished cou-
pling is a powerful, independent determinant of arrhythmo-
genesis in the setting of acute regional ischemia. These
results suggest that if it were possible to enhance intercel-
lular coupling in the heart, the risk of spontaneous ventric-
ular arrhythmias would be reduced when the myocardium
became acutely ischemic. However, enhanced coupling
could have other consequences in ischemic heart disease.
Closure of gap junction channels does not occur until late in
the development of acute injury in ischemic cardiac myo-
cytes, and previous studies have indicated that intercellular
chemical transmission could promote the spread of injury
(6–9). In the present study, we tested the hypothesis that
diminished coupling results in smaller myocardial infarcts
(MIs) in Cx43/ mice compared with wild-type
(Cx43/) mice after coronary occlusion. We ligated the
left anterior descending coronary artery (LAD) to create MI
in Cx43/ and Cx43/ mice, and we characterized
post-MI remodeling and measured infarct size in healing
and fully healed infarcts.
METHODS
Cx43/ and Cx43/ mice. Founder mice (C57BL/6J-
Gjaltm1Kdr) of uniform genetic background (C57BL/6) were
originally purchased from Jackson Laboratories (Bar Har-
bor, Maine) and inbred in a standard barrier facility under
veterinary supervision. Genotypes were determined by poly-
merase chain reaction, as described previously (5). All
protocols conformed to the “Position of the American
Heart Association on Research Animal Use,” adopted by
the Association in November 1984, and were approved by
the Animal Studies Committee at Washington University
School of Medicine.
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Surgery for MI. All operations were performed by the
same individual (S.K.) who was blinded to the genotype.
Typically, groups of 6 to 10 animals of both genotypes were
operated in random order at a single setting. Animals were
anesthetized with an intraperitoneal injection of ketamine
(87 mg/kg) and xylazine (13 mg/kg). The trachea was
exposed through a mid-line incision and intubated with a
20-gauge intravenous catheter through the oral pharynx.
Respiration was controlled by a ventilator at a tidal volume
of 0.7 to 1.0 ml and a rate of 130 to 150 strokes/min. The
chest was opened by a left thoracotomy through the fifth
intercostal space. A 7-0 prolene suture was tied around the
LAD immediately distal to the origin of the first diagonal
branch. Animals were weaned from the respirator and
allowed to recover from anesthesia on a heating mat. Sham
operations were performed in the identical manner, except
that the LAD was not ligated.
Echocardiography. All echocardiographic studies and in-
terpretations were performed by a single observer (A.K.)
who was blinded to the genotype. Echocardiographic mea-
surement of infarct size and characterization of post-MI
remodeling by measuring left ventricular (LV) end-diastolic
volume, LV mass, and ejection fraction were performed in
subsets of Cx43/ and Cx43/ mice with MI, using
methods described and validated previously (10). Two
groups of animals were studied. In the first group, 13
Cx43/ and 10 Cx43/ mice underwent echocardio-
graphic analysis one and seven days after MI. This approach
permitted analysis of the relative change in LV structure and
function within individual hearts during the first post-MI
week. These animals were sacrificed on day 8 after MI, and
infarct size was measured histologically, as described subse-
quently. Echocardiographic findings in the 10 control mice
(Cx43/) already described have been reported in a previ-
ous study designed to validate the echocardiographic meth-
ods (10). A second group of eight Cx43/ and 10
Cx43/ mice underwent echocardiographic assessment of
infarct size and post-MI remodeling 10 weeks after MI to
allow comparison of remodeling at 1 and 10 weeks after MI.
These animals were sacrificed, and infarct size was measure-
ment histologically 10 weeks after MI.
Histologic analysis of infarct size. Infarct size was mea-
sured in 30 Cx43/ and 23 Cx43/ hearts containing
healing infarcts (8 days after MI surgery) and in nine
Cx43/ and 17 Cx43/ hearts containing fully healed
infarcts (10 weeks after MI surgery). These groups included
hearts of mice analyzed by echocardiography and others not
analyzed by echocardiography. All investigators were
blinded to the genotype. Excised hearts were fixed in
formalin, cut transversely into three roughly equal short-axis
ventricular slices (apical, middle, and basal portions), em-
bedded in paraffin, and sectioned in their entirety at a
thickness of 5 m. Every 20th section was collected on an
individual glass slide yielding 24 to 30 slides per heart.
Sections from the approximate mid-points of the three
short-axis ventricular slices were stained with Masson’s
trichrome stain for quantitative analysis of infarct size and
structure. Infarct size was measured using a computerized
morphometric system and National Institutes of Health
Image software. The portions of each of the three short-axis
ventricular sections occupied by infarct scar and the non-
infarcted LV free wall and interventricular septum were
traced; areas were measured and summed; and infarct size
was calculated as the total area occupied by scar divided by
the total ventricular area (infarcted plus non-infarcted ar-
eas). In previous validation studies (10), morphometric
measurements were made in nine different sections (three
sections each from the basal, middle, and apical ventricular
slices). No significant differences were observed in infarct
size based on analysis of three as opposed to nine separate
sections. Thus, infarct sizes in the present study were
determined in three ventricular sections.
Statistical analysis. All data are expressed as the mean
value  SD. Differences in infarct size between genotypes
were determined by the Mann-Whitney rank-sum test,
which was used because the infarct size data were not
normally distributed.
RESULTS
Pathologic features of MI. Discrete infarcts were identi-
fied in all mice that underwent successful LAD ligation. As
shown in Figure 1, some were small, localized infarcts, but
most involved much of the anteroapical LV. The largest
infarcts also included the lateral and posterolateral free
walls, but the interventricular septum was generally spared.
The subendocardium was involved in all infarcts, including
the smallest. Sham-operated animals showed focal epicar-
dial fibrosis localized immediately to the site of LAD
manipulation, but none showed subendocardial fibrosis.
Thus, MI was related to occlusion of the LAD rather than
to other effects of surgery. When examined eight days after
MI surgery, infarcts were composed of granulation tissue
containing newly deposited collagenous matrix, residual
mononuclear inflammatory infiltrate, and numerous small
blood vessels (Fig. 1). Fully healed infarcts examined 10
weeks after MI surgery were composed of dense scar tissue
virtually devoid of cells and blood vessels (Fig. 1).
Echocardiographic analysis. Changes in LV structure and
function were monitored one and seven days and 10 weeks
after MI in selected Cx43/ and Cx43/ mice, all of
Abbreviations and Acronyms
Cx43  connexin43
Cx43/  mice with two wild-type alleles for the Cx43
gene
Cx43/  mice with one null allele for the Cx43 gene
LAD  left anterior descending coronary artery
LV  left ventricle or ventricular
MI  myocardial infarct or infarction
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which were subsequently analyzed by histologic measure-
ment of infarct size. As reported previously (10), there was
an excellent correlation between infarct size estimated by
echocardiography and that measured by histology (correla-
tion coefficients 0.92 and 0.77 for 1- and 10-week time
points, respectively). There were also no significant differ-
ences in infarct sizes between groups of Cx43/ and
Cx43/ mice that were subjected to echocardiography and
those analyzed only histologically. Structural and functional
evidence of LV remodeling was observed during the first
week of infarct healing in hearts with moderate to large
infarcts. As shown in Figure 2, both Cx43/ and Cx43/
mice showed a direct relationship between the relative
increase from one day to one week after MI in LV
end-diastolic volume and LV mass and infarct size. De-
creasing ejection fraction was also observed with increasing
infarct size in both groups during this interval. Echocardio-
graphic analysis was also performed in Cx43/ and
Cx43/ mice with fully healed infarcts 10 weeks after MI.
Sham-operated mice of both genotypes (n  5) had a LV
end-diastolic volume of 34 9 l, LV mass of 57 11 mg,
and ejection fraction of 70  2%. These values were the
same as those obtained from hearts with very small infarcts
at either 1 or 10 weeks after MI. Figure 3 compares LV
end-diastolic volume and ejection fraction as a function of
infarct size measured 1 and 10 weeks after MI in Cx43/
and Cx43/ mice. These echocardiographic findings indi-
cate that post-MI remodeling varies as a function of infarct
size in both Cx43/ and Cx43/ mice, and this relation-
ship is not affected by diminished Cx43 expression.
Relationship between Cx43 expression level and infarct
size. As shown in Figure 4, infarcts were smaller in
Cx43/ than in Cx43/ hearts. In hearts excised eight
days after MI surgery, the mean infarct size, expressed as a
percentage of total LV area, was 29% smaller in Cx43/
hearts (17  14% of total LV area, n  30) than in
Cx43/ hearts (24  15%, n  23; p  0.037). Absolute
infarct size (total area of scar in the apical, middle, and basal
sections) was 28% smaller in Cx43/ hearts (5.4  4.4
mm2) than in Cx43/ hearts (7.5  4.4 mm2; p  0.049),
whereas the total area of infarcted plus non-infarcted
segments summed across the three separate sections was the
same in Cx43/ (32.5  4.8 mm2) and Cx43/ (31.9 
4.3 mm2; p  0.627) hearts. These observations are con-
Figure 1. Representative trichrome-stained sections of mouse myocardial infarcts. (Left) A typical anteroapical infarct (arrow) observed eight days after MI
surgery. (Center) Edematous, highly cellular granulation tissue with residual necrotic muscle (arrow) in a healing infarct (bar  50 m). (Right) Mature,
sparsely cellular scar tissue in a fully healed infarct (bar  100 m).
Figure 2. Changes in left ventricular end-diastolic volume (LVVd) (A) and left ventricular (LV) mass (B) between days 1 and 7 after myocardial infarction
and LV ejection fraction on day 7 (C) as a function of infarct size measured echocardiographically in Cx43/ (solid circles) and Cx43/ (open circles)
mice.
683JACC Vol. 41, No. 4, 2003 Kanno et al.
February 19, 2003:681–6 Myocardial Infarct Size in Cx43-Deficient Mice
sistent with echocardiographic findings and indicate that
smaller infarcts in Cx43/ hearts at this phase of remod-
eling during infarct healing were the result of a smaller
amount of tissue that became necrotic, rather than a larger
amount of post-MI hypertrophy of non-infarcted segments.
In hearts excised 10 weeks after MI surgery, infarcts were
smaller (by 50%) in Cx43/ hearts (6  5%, n  9) than
in Cx43/ hearts (12  7%, n  17; p  0.037). Overall,
the size of fully healed infarcts was considerably less than
the size of healing infarcts, owing to complete resorption of
necrotic muscle, a decline of inflammatory cells and blood
vessels in the granulation tissue seen in healing infarcts, and
maturation of the granulation tissue matrix into dense
fibrous scar tissue. The reproducibility of intraobserver and
interobserver measurements of infarct size was good (reli-
ability coefficient  0.98).
DISCUSSION
The major finding in this study is that Cx43/ mice
developed significantly smaller infarcts than wild-types
when the LAD was ligated at the same point in both
groups. This result indicates that a reduction of 50% in
Cx43 expression is an independent determinant of the size
of an infarct created by persistent coronary occlusion. The
underlying mechanisms may be multiple. One possibility is
that Cx43/ mice developed a smaller region at risk for
infarction because of differences in the structure and/or
function of the coronary circulation. In a previous study (5),
no differences were seen in the size of the hypoperfused
zone measured by a dye-perfusion method in isolated,
perfused Cx43/ and Cx43/ hearts 60 min after ligation
of the LAD (53  9% and 58  15% of total LV area was
unstained in Cx43/ and Cx43/ hearts, respectively; n
 6 for each; p  0.5). Thus, major differences in collateral
vessels at the onset of LAD occlusion or blood flow patterns
after occlusion probably do not account for the smaller
infarcts observed in Cx43/ mice. A more likely reason
may be decreased intercellular transmission of biochemical
mediators of ischemic injury. This hypothesis is supported
by the results of previous studies.
Garcia-Dorado et al. (6) have reported that hypercon-
tracture induced by microinjection of Ca2 into one cell in
a pair of isolated myocytes was transmitted to the other cell,
and this process was blocked by the gap junction uncoupler
heptanol. Adding heptanol during reoxygenation of hypoxic
rat hearts improved recovery of contractile function and
decreased necrosis (6). The addition of heptanol during
reperfusion also reduced the infarct size in pig hearts
subjected to coronary occlusion in vivo (6). Lin et al. (7)
showed that forced expression of bcl-2 in C6 glioma cells
increased cellular resistance to injury, but this effect was
diminished when bcl-2–expressing cells were coupled by gap
junctions to nontransfected cells. Yasui et al. (8) reported
that inhibition of Cx43 synthesis by antisense oligonucleo-
tides in cultured neonatal rat myocytes decreased dye
coupling and increased the progression of apoptosis during
five days in culture. Ruiz-Meana et al. (9) showed that
intercellular passage of the dye Lucifer yellow, a functional
marker of gap junction coupling, still occurred 10 min after
the onset of rigor in isolated myocyte pairs subjected to
simulated ischemia, as well as 30 min after rigor developed
in isolated rat hearts subjected to no-flow ischemia. Taken
together, these studies suggest that gap junction communi-
cation persists for some time after the onset of myocardial
ischemia and that intercellular transfer of molecules may
either limit or promote injury depending on experimental
conditions.
It is difficult to achieve a defined steady-state level of
uncoupling with the use of chemical uncouplers or antisense
oligonucleotides and to avoid potential nonspecific effects of
chemical uncouplers such as heptanol. Cx43/ mice have
the advantage of a defined reduction in Cx43 expression,
but because cardiac myocytes are so well coupled, it has been
suggested that a reduction of50% in Cx43 expression may
have little functional impact under basal physiologic condi-
tions (11). However, under pathophysiologic conditions, a
Figure 3. Left ventricular (LV) end-diastolic volume (A) and ejection
fraction (B) as a function of infarct size measured one week (triangles) and
10 weeks (squares) after myocardial infarction (MI) in Cx43/ (solid
symbols) and Cx43/ (open symbols) mice.
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more dramatic phenotype can be elicited in Cx43/ mice.
For example, LAD occlusion in isolated, perfused hearts
producing acute regional ischemia leads to a significantly
greater incidence and earlier onset of ventricular tachyar-
rhythmias in Cx43/ compared with Cx43/ mice. Of
particular relevance to the present study is a recent report by
Suishansian et al. (12), who observed significantly larger
cerebral infarcts in Cx43/ compared with Cx43/ mice
subjected to middle cerebral artery occlusion. Unlike the
situation in the heart in which cardiac myocytes are exten-
sively coupled by gap junctions, neurons within the brain are
not connected by gap junctions. However, glial cells are
interconnected by gap junctions, and it is thought that one
mechanism by which glia protect neurons at sites of acute
injury is uptake of extracellular glutamate and other bio-
chemical mediators of injury and dissipation via intercellular
transfer through gap junctions. If this mechanism is oper-
ative, then diminished expression of Cx43 would increase
neuronal injury and lead to larger cerebral infarcts. Al-
though the role of gap junction coupling as a determinant of
infarct size may differ in the heart and brain, the results of
the present study and the study by Suishansian et al. (12)
indicate that an 50% reduction in Cx43 expression has a
clear impact on the extent of tissue injury in both coronary
and cerebral artery occlusion models.
Study limitations and clinical implications. Considerable
circumstantial evidence suggests that remodeling of gap
junctions in patients with healed infarcts causes slow con-
duction and uni-directional conduction block, which con-
tribute to reentrant arrhythmogenesis (13–16). Although
reduced Cx43 expression enhances arrhythmogenesis in
response to acute myocardial ischemia (5), the results of the
present study add considerable weight to the idea that
reduced gap junction communication also diminishes infarct
size. Uncoupling during acute ischemia may therefore serve
multiple adaptive roles. Echocardiographic quantification of
post-MI remodeling in mice is technically challenging, and
we did not independently measure changes in ventricular
volumes and ejection fractions. It must also be acknowl-
edged that surgery to produce MI in mice is difficult.
Although infarcts were consistently smaller in Cx43/
hearts, infarcts occurred over a considerable range of sizes in
both genotypes, perhaps related to technical factors. The
mechanisms responsible for smaller infarcts in Cx43/
mice remain a matter of speculation. Although it is likely
that reduced coupling was responsible, secondary effects of
Cx43 deficiency could have contributed indirectly. It may be
argued, however, that attempts to reduce lethal arrhythmias
in patients by improving gap junction communication may
carry certain risks with regard to the extent of subsequent
ischemic injury and post-MI remodeling.
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Figure 4. Infarct size measured histologically 8 days and 10 weeks after left anterior descending coronary artery occlusion in Cx43/ and Cx43/ mice.
LV  left ventricular; MI  myocardial infarction. *p  0.037.
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